Cefiderocol for treating severe drug-resistant gram-negative bacterial infections (HTE2)Product type:GuidanceProgramme:Health technology evaluationPublished: 17 August 2022
Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections (HTE1)Product type:GuidanceProgramme:Health technology evaluationPublished: 17 August 2022
Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies: early value assessment (HTE6)Product type:GuidanceProgramme:Health technology evaluationLast updated: 10 August 2023Published: 30 March 2023
Point-of-care tests for urinary tract infections to improve antimicrobial prescribing: early value assessment (HTE7)Product type:GuidanceProgramme:Health technology evaluationPublished: 4 May 2023